Agilent

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agilent and other ETFs, options, and stocks.

About A

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. 

CEO
Padraig Mcdonnell
CEOPadraig Mcdonnell
Employees
18,100
Employees18,100
Headquarters
Santa Clara, California
HeadquartersSanta Clara, California
Founded
1999
Founded1999
Employees
18,100
Employees18,100

A Key Statistics

Market cap
33.45B
Market cap33.45B
Price-Earnings ratio
25.91
Price-Earnings ratio25.91
Dividend yield
0.86%
Dividend yield0.86%
Average volume
2.00M
Average volume2.00M
High today
$120.17
High today$120.17
Low today
$117.23
Low today$117.23
Open price
$119.60
Open price$119.60
Volume
895.80K
Volume895.80K
52 Week high
$160.27
52 Week high$160.27
52 Week low
$104.36
52 Week low$104.36

Stock Snapshot

Agilent(A) stock is priced at $118.36, giving the company a market capitalization of 33.45B. It carries a P/E multiple of 25.91 and pays a dividend yield of 85.6%.

On 2026-05-06, Agilent(A) stock traded between a low of $117.23 and a high of $120.17. Shares are currently priced at $118.36, which is +1.0% above the low and -1.5% below the high.

The Agilent(A)'s current trading volume is 895.8K, compared to an average daily volume of 2M.

During the past year, Agilent(A) stock moved between $104.36 at its lowest and $160.27 at its peak.

During the past year, Agilent(A) stock moved between $104.36 at its lowest and $160.27 at its peak.

A News

Simply Wall St 10h
Assessing Agilent Technologies Valuation After FDA Companion Diagnostic Approval For Esophageal Cancer

Agilent Technologies (A) is drawing fresh attention after the FDA approved its PD-L1 IHC 22C3 pharmDx test as the only companion diagnostic for certain esophage...

Assessing Agilent Technologies Valuation After FDA Companion Diagnostic Approval For Esophageal Cancer
Simply Wall St 2d
Does Agilent’s New Chief Legal Officer Shift the Risk‑Reward Balance in Its Strategy?

Agilent Technologies has recently completed a leadership transition, appointing Michael Buckner as Chief Legal Officer after Bret DiMarco resigned and moved int...

Does Agilent’s New Chief Legal Officer Shift the Risk‑Reward Balance in Its Strategy?
TipRanks 2d
Agilent appoints Michael Buckner as CLO

Agilent Technologies (A) announced the appointment of Michael Buckner as chief legal officer. Buckner joins Agilent from Danaher Corp. (DHR), where he served as...

Analyst ratings

81%

of 21 ratings
Buy
81%
Hold
19%
Sell
0%

More A News

TipRanks 2d
Agilent Names New Chief Legal Officer Amid Leadership Transition

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own A. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.